Before Next Nvidia-Style Run: 3 AI Stocks to Watch
The AI boom isn’t a one-stock story. Here are three well-positioned names beyond Nvidia that could fuel the next rall...
Articles — Page 1191
Microsoft's Split with OPENAI Could Boost Stock Long-Term
As AI accelerates,Microsoft's split with OPENAI could reshape strategy and investor returns. Learn what this means fo...
JPMorgan Chase Says Comfortable: Investors & Private Credit
Private credit has grown rapidly, bringing yield and risk in equal measure. This article breaks down what JPMorgan Ch...
Iradimed’s Founder Sold 7,500: Key Investor Takeaways
When insiders move stock, investors pay attention. This article breaks down what iradimed’s founder sold 7,500 means ...
This Social Security Surprise Could Upend Your Retirement Budget
A hidden wrinkle in Social Security planning could shake up your retirement budget. This article breaks down what to ...
Global Inventories 11-Year Getting Tight: Investor Guide
Oil markets are tight and volatile as global inventories 11-year getting tighter. This guide explains what it means f...
Booking Holdings Airbnb: What Investors Should Know
Two leading travel platforms, Booking Holdings and Airbnb, each chart different revenue paths. This article breaks do...
FinVolution (FINV) 2026 Earnings: Outlook, Risks, and Opportunities
A practical guide to understanding finvolution (finv) 2026 earnings, what to watch in the Q1 transcript, and how to p...
This Stock Been Called Overvalued: Bears Still Lose
Critics have labeled this stock as overvalued for years, yet its price action and earnings trajectory tell a differen...
Vail Resorts Stock After Oasis Buy: Outlook for Investors
Oasis Management revealed a sizable new stake in Vail Resorts, boosting its position by 237,162 shares in Q1. This ar...
401(k) Balance Over $900,000 Elevates Social Security Taxes
A retiree with a large 401(k) balance faces steep taxation on Social Security under a rule unchanged since 1984. The ...
Lilly Just Huge Vote: Morgan Stanley Bets on Mounjaro
A major investment bank just signaled a powerful vote of confidence in Lilly's GLP-1 strategy. This article breaks do...